India's Biocon files IPO prospectus for R&D arm Syngene

April 23, 2015 4:15 AM

2 0

MUMBAI, April 23 (Reuters) - Indian biotech firm Biocon Ltd has filed a prospectus for the initial public offering of its $600 million research and development arm, Syngene, it said on Thursday.

The company plans to sell 22 million shares, including an overallotment, it said in a statement, after the prospectus was filed with India's market regulator.

Also read: Dow gains 100 points amid deluge of corporate news; real estate leads

Read more

To category page